FDA Drug Application (021003) for EPIVIR-HBV by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number021003
Product Number001
FormTABLET;ORAL
Dosage100MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameEPIVIR-HBV
Active IngredientLAMIVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39


Back to FDA Applications sponsored by GLAXOSMITHKLINE